Etisomicin

This classification denotes an antibiotic with the molecular formula C20H39N5O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0BZK9FE5DE, chemically known as o-3-deoxy-3-(ethylamino)-4-c-methyl-beta-l-arabinopyranosyl-(1->4)-o-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-d-glycero-hex-4-enopyranosyl-(1->6))-2-deoxy-l-streptamine. but more generally known as etisomicin, which bears US NIH Compound Identifier 216268. European Medicines Agency schedules Etisomicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07311MIG. The term ETISOMICIN is an International Non-Proprietary Name. ETISOMICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1C(O)C(OC2OC(=CCC2N)CN)C(N)CC1N)C1OCC(O)(C(NCC)C1O)C.